| PRD_000955 | Name: | 3-hydroxy-N-{(2S,3R)-3-hydroxy-4-[(2-methylpropyl){[5-(1,2-oxazol-5-yl)thiophen-2-yl]sulfonyl}amino]-1-phenylbutan-2-yl}benzamide | Formula: | C28 H31 N3 O6 S2 | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000959 | Name: | 4-(benzyloxy)-N-[(2S,3R)-3-hydroxy-1-{[(2S)-1-{[(3-methylthiophen-2-yl)methyl]amino}-1-oxo-4-phenylbutan-2-yl]amino}-1-oxobutan-2-yl]benzamide | Formula: | C34 H37 N3 O5 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000964 | Name: | N-(benzylsulfonyl)-D-alanyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide | Formula: | C23 H29 Cl N4 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000971 | Name: | N-acetylglycyl-N-[(3S)-1-hydroxy-5-methyl-2-oxohexan-3-yl]-L-serinamide | Formula: | C14 H25 N3 O6 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000972 | Name: | N-(benzylsulfonyl)-D-valyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide | Formula: | C25 H33 Cl N4 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000980 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-methyl-L-leucinamide | Formula: | C16 H26 N3 O5 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000981 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-alanine | Formula: | C18 H28 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000982 | Name: | (2S)-2-({N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl}amino)butanoic acid | Formula: | C19 H30 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000983 | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-norvaline | Formula: | C20 H32 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000984 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-isoleucine | Formula: | C21 H34 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000985 | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-ethyl-L-leucinamide | Formula: | C17 H28 N3 O5 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000986 | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucylglycine | Formula: | C17 H26 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000987 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-valine | Formula: | C20 H32 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_000991 | Name: | 1,2,4-trideoxy-4-methyl-2-{[N-(morpholin-4-ylacetyl)-L-alanyl-O-methyl-L-tyrosyl]amino}-1-phenyl-D-xylitol | Formula: | C31 H44 N4 O7 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001001 | Name: | RITONAVIR | Formula: | C37 H48 N6 O5 S2 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001003 | Name: | N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide | Formula: | C32 H45 N5 O3 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001005 | Name: | N-(benzylsulfonyl)-3-cyclohexyl-D-alanyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide | Formula: | C29 H39 Cl N4 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001008 | Name: | N~2~-(benzylsulfonyl)-D-arginyl-N-(4-carbamimidoylbenzyl)glycinamide | Formula: | C23 H32 N8 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001011 | Name: | (3S)-4-hydroxy-3-{[(2S)-4-{[2-(2-methyl-1H-benzimidazol-1-yl)ethyl]amino}-2-(1-methylethyl)-4-oxobutanoyl]amino}butanoic acid | Formula: | C21 H30 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001017 | Name: | (S)-N-((1R,2S)-1-((2R,3R)-3-benzyloxiran-2-yl)-1-hydroxy-3-phenylpropan-2-yl)-3-methyl-2-(2-phenoxyacetamido)butanamide | Formula: | C31 H36 N2 O5 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001019 | Name: | (S)-N-((2S,3S,4R,5R)-4-amino-3,5-dihydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-phenoxyacetamido)butanamide | Formula: | C31 H39 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001032 | Name: | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4-DIONYL]-ISOLEUCYL-PROLINE | Formula: | C18 H31 N3 O6 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001038 | Name: | 3-[[(2S)-2-[[[(2S)-2-[[(2S)-2-[[(2S)-2-azanyl-3-(1H-1,2,3,4-tetrazol-5-ylcarbonylamino)propanoyl]amino]-3-methyl-butanoyl]amino]-4-methyl-pentanoyl]amino]methyl]-2-hydroxy-4-phenyl-butanoyl]amino]benzoic acid | Formula: | C34 H46 N10 O8 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001046 | Name: | N-(benzylsulfonyl)-O-tert-butyl-D-seryl-N-(4-carbamimidoylbenzyl)glycinamide | Formula: | C24 H33 N5 O5 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
| PRD_001050 | Name: | N~2~-acetyl-N-{(1R)-1-[(S)-[(2S)-3-{[(2S)-1-amino-1-oxopropan-2-yl]amino}-2-methyl-3-oxopropyl](hydroxy)phosphoryl]-2-phenylethyl}-L-alpha-asparagine | Formula: | C21 H31 N4 O8 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|